You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Pfs25

Showing 1 - 25 of 4,694
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Malaria Trial in Bamako (biological, other, drug)

Completed
Has Results
  • Malaria
  • Pfs25M-EPA
  • +6 more
  • Bamako, Mali
    Bancoumana Malaria Vaccine Center
Jan 27, 2022

Malaria,Falciparum Trial in Oxford (Pfs25-IMX313/Matrix-M1)

Terminated
  • Malaria,Falciparum
  • Pfs25-IMX313/Matrix-M1
  • Oxford, United Kingdom
    CCVTM, University of Oxford, Churchill Hospital
Sep 25, 2020

Recurrent Hodgkin Lymphoma, Refractory Hodgkin Lymphoma Trial in Duarte (Basiliximab, Carmustine, Cytarabine)

Recruiting
  • Recurrent Hodgkin Lymphoma
  • Refractory Hodgkin Lymphoma
  • Basiliximab
  • +6 more
  • Duarte, California
    City of Hope Medical Center
Jun 16, 2022

Episodic Migraine Trial in Worldwide (AMG334 (70 mg) Pre-Filled Syringe (PFS), Placebo Pre-Filled Syringe (PFS))

Completed
Has Results
  • Episodic Migraine
  • AMG334 (70 mg) Pre-Filled Syringe (PFS)
  • Placebo Pre-Filled Syringe (PFS)
  • Heidelberg, Australia
  • +58 more
Feb 23, 2022

Malaria Trial in Bethesda, Bamako (Pfs230D1M-EPA/Alhydrogel, Pfs25M-EPA/Alhydrogel, TWINRIX)

Completed
  • Malaria
  • Pfs230D1M-EPA/Alhydrogel
  • +3 more
  • Bethesda, Maryland
  • +1 more
Apr 10, 2019

Malaria, Malaria Vaccines, Plasmodium Falciparum Malaria Trial (Malaria Transmission-Blocking Pfs25-Pfs25 Conjugate Vaccine)

Withdrawn
  • Malaria
  • +2 more
  • Malaria Transmission-Blocking Pfs25-Pfs25 Conjugate Vaccine
  • (no location specified)
Jul 3, 2018

Malaria Trial in Bamako (Pfs25-EPA/Alhydrogel, Euvax B, Menactra)

Completed
  • Malaria
  • Pfs25-EPA/Alhydrogel
  • +2 more
  • Bamako, Mali
    Malaria Research and Training Center
Jul 3, 2018

Malaria,Falciparum Trial in Bamako (Pfs230D1-EPA/Matrix-M Vaccine, Verorab Rabies Vaccine)

Active, not recruiting
  • Malaria,Falciparum
  • Pfs230D1-EPA/Matrix-M Vaccine
  • Verorab Rabies Vaccine
  • Bamako, Mali
    Malaria Research Training Center
Sep 7, 2022

Lung Cancer, Non-squamous, Non-small Cell Trial (zongertinib, pembrolizumab, cisplatin)

Not yet recruiting
  • Lung Cancer, Non-squamous, Non-small Cell
  • (no location specified)
Nov 22, 2023

Precision Medicine Treatment for Refractory Solid Tumors

Recruiting
  • Refractory Solid Tumors
  • Next Generation Sequencing
    • Tianjin, Tianjin, China
      Tianjin Medical University Second Hospital
    Sep 2, 2023

    Lymphoma, Large B-Cell, Diffuse Trial (Cyclophosphamide, TLI, Fludarabine)

    Not yet recruiting
    • Lymphoma, Large B-Cell, Diffuse
    • (no location specified)
    Aug 18, 2023

    Driven by Disease Biology et/or Immunoactivity (PROMETEO)

    Recruiting
    • Oligometastatic Prostate Cancer
      • Aviano, Pordenone, Italy
      • +1 more
      Sep 25, 2023

      Pancreatic Adenocarcinoma, Homologous Recombination Deficiency Trial (Cisplatin)

      Not yet recruiting
      • Pancreatic Adenocarcinoma
      • Homologous Recombination Deficiency
      • (no location specified)
      Oct 18, 2023

      Lung Cancer Stage IV Trial in Maastricht (Radiation)

      Not yet recruiting
      • Lung Cancer Stage IV
      • Radiation
      • Maastricht, Netherlands
        Maastricht Radiation Oncology (Maastro)
      Aug 29, 2023

      Newly Diagnosed Peripheral T-cell Lymphoma Trial in Nanjing (C-BEAM Regimen, BEAM Regimen)

      Recruiting
      • Newly Diagnosed Peripheral T-cell Lymphoma
      • C-BEAM Regimen
      • BEAM Regimen
      • Nanjing, Jiangsu, China
        Hematological Department, People's Hospital of Jiangsu Province
      Jun 27, 2023

      Estrogen-receptor-positive Breast Cancer, HER2/Neu-Negative Breast Cancer, Advanced Breast Cancerv Trial in Chicago

      Not yet recruiting
      • Estrogen-receptor-positive Breast Cancer
      • +3 more
      • elacestrant, palbociclib, abemaciclib, ribociclib
      • Chicago, Illinois
        Northwestern University
      Sep 25, 2023

      NSCLC Trial in Worldwide (Nivolumab, Ipilimumab, BMS-986207)

      Terminated
      • Non-Small Cell Lung Cancer
      • Tucson, Arizona
      • +70 more
      Jan 31, 2023

      Advanced NSCLC Trial in Jinan (almonertinib)

      Recruiting
      • Advanced Non-small Cell Lung Cancer
      • Jinan, Shandong, China
        Degan Lu
      Sep 12, 2023

      HER2-positive Breast Cancer Trial in Nanjing (HS022, Trastuzumab, Vinorelbine Bitartrate)

      Completed
      • HER2-positive Breast Cancer
      • Nanjing, Jiangsu, China
        Jiangsu Province People's Hospital (First Affiliated Hospital of
      Oct 25, 2023

      Large B-cell Lymphoma, Diffuse Large B Cell Lymphoma Trial in Homburg (R-miniCHOP + Acalabrutinib, R-miniCHOP)

      Not yet recruiting
      • Large B-cell Lymphoma
      • Diffuse Large B Cell Lymphoma
      • Homburg, Saarland, Germany
        Saarland University Medical Center
      Apr 19, 2023

      Metastatic Breast Cancer Trial (SKB264, Eribulin, Capecitabine)

      Not yet recruiting
      • Metastatic Breast Cancer
      • (no location specified)
      Oct 7, 2023

      Unresectable or Metastatic Microsatellite Stable/Mismatch Repair Proficient Colorectal Cancer Trial in Australia, China

      Recruiting
      • Unresectable or Metastatic Microsatellite Stable/Mismatch Repair Proficient Colorectal Cancer
      • Benowa, Queensland, Australia
      • +7 more
      Jan 30, 2023

      HER2-positive Advanced Breast Cancer Trial (DP303c, Trastuzumab, Vinorelbine Tartrate)

      Not yet recruiting
      • HER2-positive Advanced Breast Cancer
      • (no location specified)
      Jun 4, 2023

      Esophageal Squamous Cell Carcinoma Trial in Nanjing (Carrelizumab, Paclitaxel injection, Cisplatin)

      Enrolling by invitation
      • Esophageal Squamous Cell Carcinoma
      • Nanjing, China
        The First Affiliated Hospital of Nanjing Medical University
      Sep 19, 2023

      Metastatic Colorectal Cancer Trial in Madison (Liposomal irinotecan, TAS102, Bevacizumab)

      Not yet recruiting
      • Metastatic Colorectal Cancer
      • Liposomal irinotecan
      • +2 more
      • Madison, Wisconsin
        University of Wisconsin Carbone Cancer Center
      May 2, 2023